Celdara Medical

8 articles about Celdara Medical

• Celdara Medical and the University of Vermont Secure NIH Funding to Improve Pandemic Preparedness and Response

  1/19/2021

  Celdara Medical, LLC announced that the National Institute of Allergy and Infectious Disease of the National Institutes of Health has awarded it a two-year Small Business Technology Transfer Research grant to fund the development of a novel, broad-spectrum therapeutic/prophylactic against RNA viruses, including SARS-CoV-2, SARS, Ebola, influenza, and pathogenic arenaviruses.

• The Pandemic Security Initiative Introduces Scientific Advisory Board Founding Members

  10/20/2020

  Celdara Medical announced the launch of the Pandemic Security Initiative's Scientific Advisory Board, a group of outstanding scientists and infectious disease experts.

• Celdara Medical Announces Receipt of NIH Funding for Pandemic Influenza Antiviral Development

  8/12/2020

  Grant Enables Development of Innovative Medicines Against Future Pandemic Threats   [12-August-2020]   CAMBRIDGE, Mass. and LEBANON, N.H. and NEW YORK, Aug. 12, 2020 /PRNewswire/ -- Celdara Medical ("Celdara")  announced that the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) has awarded a Small Business Innovatio

• Celdara Medical Announces the Pandemic Security Initiative

  7/14/2020

  Celdara Medical ("Celdara") today announced the launch of its Pandemic Security Initiative, harnessing the resources needed to prepare the nation for future infectious disease pandemics.

• 

  BIO Preview: Some of the Highlights of One of the World’s Premier Life Science Conventions

  5/30/2019

  Here's a preview of just a handful of opportunities, companies and speakers and what they’re presenting.

• Celyad Announces New Agreements With Celdara Medical And Dartmouth College

  8/4/2017

• NIH Awards $1.7 Million Grant For Celdara Medical And Pulmatrix To Develop An Inhaled Biologic Treatment For Idiopathic Pulmonary Fibrosis

  10/1/2015

• Daiichi Sankyo, Inc., Virtici And Celdara Medical Announce Collaboration To Identify And Progress High Potential Therapeutics

  1/8/2014